Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
Clinical trial NCT01161511 · COMPLETED
Trial details
- NCT number
- NCT01161511
- Sponsor
- Xencor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.